Home 
HOME Bratislava Medical Journal 2021 Bratislava Medical Journal Vol.122, No.2, p.158–160,2021
HOME Bratislava Medical Journal 2021 Bratislava Medical Journal Vol.122, No.2, p.158–160,2021
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.122, No.2, p.158–160,2021 |
||
| Title: Association of polypharmacy and Parkinson’s disease prevalence | ||
| Author: Y. Chen, Z. Yu | ||
| Abstract: OBJECTIVE: Polypharmacy and multiple diseases are common in geriatric practice; however, such kind of multiple interventions might result in adverse effects. Some previous studies have found the association of polypharmacy and Parkinson’s disease, to confirm this relationship, we conducted a meta-analysis to analyze this issue quantitively. MATERIALS AND METHODS: In total, we included 8 studies, 165,689 polypharmacy subjects and 373,660 non-polypharmacy controls, and 5644 PD patients among these subjects and controls. RESULTS: For model without any adjustment, polypharmacy group has a significantly higher prevalence than control, OR = 2.53, 95 %CI [2.00, 3.20] (p < 0.001). However, this model showed a very high heterogeneity (I2 = 91 %, p < 0.001). In age, gender and disease history adjusted model, polypharmacy group has a significantly higher prevalence than control, OR = 1.43, 95 %CI [1.35, 1.52], p < 0.001. The heterogeneity decreased to zero (I2 = 0 %, p < 0.45). CONCLUSION: In this study we have found an association between PD risk and polypharmacy, a better designed prospective long-term cohort study might be required for further discussion on this issue (Tab. 1, Fig. 5, Ref. 14). |
||
| Keywords: polypharmacy, PD, Parkinson, meta-analysis | ||
| Published online: 26-Jan-2021 | ||
| Year: 2021, Volume: 122, Issue: 2 | Page From: 158, Page To: 160 | |
| doi:10.4149/BLL_2021_024 |
||
|
|
 download file |
|